Skip to main content

Guidance Documents

1272 Results
Guidance Documents

Questions and Answers on the Application of the ADA's Integration Mandate and Olmstead v. L.C. to Employment and Day Services for People with Disabilities

This document discusses and explains the requirements of the ADA's integration mandate and the Supreme Court's decision in Olmstead v. L.C. ex rel. Zimring, 527 U.S. 581 (1999), as applied to segregated employment settings and facility-based day programs.

ID: CRT-1814721
Components Civil Rights Division, Civil Rights - Disability Rights Section
Date Issued: October 31, 2023
Guidance Documents

DEA-Practitioner Training or Continuing Education Requirement for Registration (EO-DEA182R1)

This is a revision of a previously approved and posted Q&A (EO-DEA182), that was not considered guidance. This Q&A provides information regarding the training requirement included in CAA of 2023.  All practitioners, who are not solely a veterinarian, must attest to satisfying the training, credentialing, or educational requirements identified in the CAA in order to obtain a new or renewal DEA registration. 

ID: DEA-DC-076
Component Diversion Control Program (DEA)
Date Issued: September 25, 2023
Guidance Documents

Required Training with Respect to Opioid Use Disorder (OUD) for DEA-Registered Practitioners (EO-DEA268)

This guidance document provides information regarding a Drug Enforcement Administration (DEA)-registered practitioner’s attestation of the training requirement in the recently enacted Consolidated Appropriations Act of 2023 (CAA).  While specifically targeted to the treatment of or screening for OUD, this training is required for all qualified practitioners applying for or renewing a registration to dispense controlled substances in schedules II-V.

ID: DEA-DC-075
Component Diversion Control Program (DEA)
Date Issued: August 31, 2023
Guidance Documents

Reporting Regulated Transactions Involving Listed Chemicals (EO-DEA280)

This guidance document provides clarification regarding the regulatory requirement for persons engaging in regulated transactions in listed chemicals to report transactions involving an extraordinary quantity, an uncommon method of payment or delivery, or other circumstances indicating a potential use of listed chemicals in violation of the law.  This guidance is being sent via email to all Drug Enforcement Administration (DEA) listed chemical registrants and regulated persons.

ID: DEA-DC-074
Component Diversion Control Program (DEA)
Date Issued: August 30, 2023
Guidance Documents

Revision of Three Previously Posted Q&As relating to Electronic Prescriptions for Controlled Substances (EPCS)(EO-DEA022R1)

This is a revision of previously approved and posted Q&As, that were published on March 31, 2020.  DEA-DC-9.  This  document replaces three of the questions posted within DEA-DC-9 and provides information regarding what EPCS is, remote identity proofing, and if qualified practitioners are allowed to use EPCS to issue prescriptions for CIII-V CS approved by the FDA for MOUD.

ID: DEA-DC-09R1
Component Diversion Control Program (DEA)
Date Issued: July 25, 2023
Guidance Documents

Open Letter to All FFLs - Licensees Providing Firearms Storage for Individuals

The Bureau of Alcohol, Tobacco, Firearms and Explosives (“ATF”) is issuing this open letter to assist Federal Firearms Licensees (“FFLs”) in understanding their obligations when they choose to provide firearm storage services to their customers and the public.

ID: DOJ-2073526
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: July 24, 2023
Guidance Documents

Pharmacist Manual (EO-DEA226)

This Practitioner’s Manual has been prepared by the DEA, Diversion Control Division, as a guide to assist practitioners in their understanding of the federal Controlled Substances Act and its implementing regulations as they pertain to their profession.

ID: DEA-DC-071
Component Diversion Control Program (DEA)
Date Issued: June 14, 2023
Guidance Documents

Explosives Industry Newsletter - June 2023

What’s In This Issue: New Chief, EIPB; Importation and Manufacture of Small Arms Ammunition and Components; Importation of Articles Pyrotechnic Marked as Display Fireworks; Indoor Storage in Residences/Dwellings; Open letter – Electronic Nicotine Delivery Systems; Distance Requirements for Ammonium Nitrate Products; Black Powder Exemption Reminder; Less Lethal Munitions Marking Requirements; ATF Ruling 2011-3 Reminder; and more.

ID: DOJ-2071316
Component Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF)
Date Issued: June 1, 2023
Guidance Documents

COVID-19 Flexibility Updates (EO-DEA277)

This document informs DEA registrants impacted by the flexibilities DEA granted during the COVID-19 PHE, which flexibilities will automatically terminate at the conclusion of the COVID-19 PHE on May 11, 2023, and which flexibilities will remain in effect after May 11, 2023 under the Opioid Crisis PHE. The document also informs DEA registrants of newly published proposed rules intended to make some exceptions related to the COVID-19 PHE permanent.

ID: DEA-DC-072
Component Diversion Control Program (DEA)
Date Issued: May 10, 2023